nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—Penbutolol—coronary artery disease	0.309	1	CrCtD
Propranolol—ADRB1—coronary artery disease	0.0548	0.39	CbGaD
Propranolol—ADRB2—coronary artery disease	0.0461	0.328	CbGaD
Propranolol—CYP2C19—coronary artery disease	0.0397	0.282	CbGaD
Propranolol—Levobunolol—Timolol—coronary artery disease	0.0375	0.183	CrCrCtD
Propranolol—Penbutolol—Timolol—coronary artery disease	0.0342	0.166	CrCrCtD
Propranolol—Carteolol—Penbutolol—coronary artery disease	0.0319	0.155	CrCrCtD
Propranolol—Levobunolol—Penbutolol—coronary artery disease	0.0319	0.155	CrCrCtD
Propranolol—Guaifenesin—Penbutolol—coronary artery disease	0.029	0.141	CrCrCtD
Propranolol—Oxprenolol—Penbutolol—coronary artery disease	0.0204	0.0993	CrCrCtD
Propranolol—Alprenolol—Penbutolol—coronary artery disease	0.0204	0.0993	CrCrCtD
Propranolol—ADRB3—Timolol—coronary artery disease	0.0174	0.0722	CbGbCtD
Propranolol—HTR1B—Penbutolol—coronary artery disease	0.0127	0.0528	CbGbCtD
Propranolol—ORM1—Penbutolol—coronary artery disease	0.0122	0.0507	CbGbCtD
Propranolol—ORM1—Pitavastatin—coronary artery disease	0.0107	0.0443	CbGbCtD
Propranolol—ADRB2—Penbutolol—coronary artery disease	0.0101	0.0419	CbGbCtD
Propranolol—ADRB1—Penbutolol—coronary artery disease	0.00993	0.0413	CbGbCtD
Propranolol—HTR1A—Penbutolol—coronary artery disease	0.00795	0.033	CbGbCtD
Propranolol—ADRB2—Timolol—coronary artery disease	0.0071	0.0295	CbGbCtD
Propranolol—ADRB1—Timolol—coronary artery disease	0.007	0.0291	CbGbCtD
Propranolol—CYP3A7—Eplerenone—coronary artery disease	0.00511	0.0212	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.00511	0.0212	CbGbCtD
Propranolol—ABCB1—Ticagrelor—coronary artery disease	0.00434	0.0181	CbGbCtD
Propranolol—CYP3A5—Clopidogrel—coronary artery disease	0.00412	0.0171	CbGbCtD
Propranolol—CYP2C19—Gemfibrozil—coronary artery disease	0.00384	0.0159	CbGbCtD
Propranolol—CYP3A5—Eplerenone—coronary artery disease	0.00383	0.0159	CbGbCtD
Propranolol—CYP1A2—Gemfibrozil—coronary artery disease	0.00354	0.0147	CbGbCtD
Propranolol—CYP2C19—Clopidogrel—coronary artery disease	0.00333	0.0138	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.00329	0.0137	CbGbCtD
Propranolol—CYP3A7—Simvastatin—coronary artery disease	0.00329	0.0137	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.00322	0.0134	CbGbCtD
Propranolol—CYP3A7—Lovastatin—coronary artery disease	0.00322	0.0134	CbGbCtD
Propranolol—CYP1A2—Clopidogrel—coronary artery disease	0.00307	0.0128	CbGbCtD
Propranolol—CYP3A7—Atorvastatin—coronary artery disease	0.00294	0.0122	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.00294	0.0122	CbGbCtD
Propranolol—CYP2C19—Telmisartan—coronary artery disease	0.00291	0.0121	CbGbCtD
Propranolol—ABCB1—Clopidogrel—coronary artery disease	0.00268	0.0112	CbGbCtD
Propranolol—ABCB1—Perindopril—coronary artery disease	0.00268	0.0112	CbGbCtD
Propranolol—CYP3A5—Rosuvastatin—coronary artery disease	0.00266	0.011	CbGbCtD
Propranolol—CYP3A4—Ticagrelor—coronary artery disease	0.0026	0.0108	CbGbCtD
Propranolol—CYP3A5—Simvastatin—coronary artery disease	0.00247	0.0103	CbGbCtD
Propranolol—CYP3A5—Pravastatin—coronary artery disease	0.00242	0.01	CbGbCtD
Propranolol—CYP3A5—Lovastatin—coronary artery disease	0.00242	0.01	CbGbCtD
Propranolol—ABCB1—Pitavastatin—coronary artery disease	0.00235	0.00975	CbGbCtD
Propranolol—ABCB1—Telmisartan—coronary artery disease	0.00235	0.00975	CbGbCtD
Propranolol—CYP2C19—Timolol—coronary artery disease	0.00234	0.00974	CbGbCtD
Propranolol—CYP3A4—Fenofibrate—coronary artery disease	0.00232	0.00964	CbGbCtD
Propranolol—ABCB1—Enalapril—coronary artery disease	0.00222	0.00924	CbGbCtD
Propranolol—ABCB1—Lisinopril—coronary artery disease	0.00222	0.00924	CbGbCtD
Propranolol—CYP3A5—Atorvastatin—coronary artery disease	0.0022	0.00915	CbGbCtD
Propranolol—CYP2C19—Rosuvastatin—coronary artery disease	0.00214	0.00891	CbGbCtD
Propranolol—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00209	0.00868	CbGbCtD
Propranolol—CYP3A5—Losartan—coronary artery disease	0.00201	0.00837	CbGbCtD
Propranolol—CYP2C19—Simvastatin—coronary artery disease	0.00199	0.00828	CbGbCtD
Propranolol—CYP2C19—Lovastatin—coronary artery disease	0.00195	0.00811	CbGbCtD
Propranolol—CYP2D6—Niacin—coronary artery disease	0.00192	0.00797	CbGbCtD
Propranolol—ABCB1—Timolol—coronary artery disease	0.00189	0.00786	CbGbCtD
Propranolol—CYP3A4—Gemfibrozil—coronary artery disease	0.00185	0.00771	CbGbCtD
Propranolol—CYP2D6—Timolol—coronary artery disease	0.00178	0.00741	CbGbCtD
Propranolol—CYP2C19—Atorvastatin—coronary artery disease	0.00178	0.00738	CbGbCtD
Propranolol—ABCB1—Ezetimibe—coronary artery disease	0.00173	0.00719	CbGbCtD
Propranolol—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00169	0.00701	CbGbCtD
Propranolol—ABCB1—Captopril—coronary artery disease	0.00166	0.00692	CbGbCtD
Propranolol—CYP2C19—Losartan—coronary artery disease	0.00162	0.00675	CbGbCtD
Propranolol—CYP3A4—Clopidogrel—coronary artery disease	0.00161	0.00668	CbGbCtD
Propranolol—ABCB1—Simvastatin—coronary artery disease	0.00161	0.00668	CbGbCtD
Propranolol—ABCB1—Pravastatin—coronary artery disease	0.00157	0.00654	CbGbCtD
Propranolol—ABCB1—Lovastatin—coronary artery disease	0.00157	0.00654	CbGbCtD
Propranolol—CYP2D6—Captopril—coronary artery disease	0.00157	0.00652	CbGbCtD
Propranolol—CYP2D6—Simvastatin—coronary artery disease	0.00152	0.0063	CbGbCtD
Propranolol—CYP1A2—Losartan—coronary artery disease	0.0015	0.00623	CbGbCtD
Propranolol—CYP3A4—Eplerenone—coronary artery disease	0.0015	0.00621	CbGbCtD
Propranolol—CYP2D6—Lovastatin—coronary artery disease	0.00148	0.00616	CbGbCtD
Propranolol—CYP2D6—Pravastatin—coronary artery disease	0.00148	0.00616	CbGbCtD
Propranolol—ABCB1—Atorvastatin—coronary artery disease	0.00143	0.00596	CbGbCtD
Propranolol—CYP2D6—Atorvastatin—coronary artery disease	0.00135	0.00561	CbGbCtD
Propranolol—CYP3A4—Enalapril—coronary artery disease	0.00133	0.00554	CbGbCtD
Propranolol—ABCB1—Losartan—coronary artery disease	0.00131	0.00545	CbGbCtD
Propranolol—CYP3A4—Ezetimibe—coronary artery disease	0.00104	0.00431	CbGbCtD
Propranolol—CYP3A4—Rosuvastatin—coronary artery disease	0.00104	0.00431	CbGbCtD
Propranolol—CYP3A4—Simvastatin—coronary artery disease	0.000963	0.004	CbGbCtD
Propranolol—CYP3A4—Lovastatin—coronary artery disease	0.000943	0.00392	CbGbCtD
Propranolol—CYP3A4—Pravastatin—coronary artery disease	0.000943	0.00392	CbGbCtD
Propranolol—CYP3A4—Atorvastatin—coronary artery disease	0.000859	0.00357	CbGbCtD
Propranolol—CYP3A4—Losartan—coronary artery disease	0.000785	0.00326	CbGbCtD
Propranolol—Cinacalcet—CASR—coronary artery disease	0.000252	0.116	CrCbGaD
Propranolol—Carvedilol—NPPB—coronary artery disease	0.000103	0.0477	CrCbGaD
Propranolol—Carvedilol—GJA1—coronary artery disease	0.000103	0.0477	CrCbGaD
Propranolol—Carvedilol—SELE—coronary artery disease	9.8e-05	0.0452	CrCbGaD
Propranolol—Carvedilol—VCAM1—coronary artery disease	9.35e-05	0.0432	CrCbGaD
Propranolol—Carvedilol—HIF1A—coronary artery disease	7.84e-05	0.0362	CrCbGaD
Propranolol—Practolol—ADRB1—coronary artery disease	6.52e-05	0.0301	CrCbGaD
Propranolol—Levobunolol—ADRB1—coronary artery disease	6.18e-05	0.0285	CrCbGaD
Propranolol—Metipranolol—ADRB1—coronary artery disease	5.89e-05	0.0272	CrCbGaD
Propranolol—Carteolol—ADRB1—coronary artery disease	5.25e-05	0.0242	CrCbGaD
Propranolol—Levobunolol—ADRB2—coronary artery disease	5.2e-05	0.024	CrCbGaD
Propranolol—Metipranolol—ADRB2—coronary artery disease	4.96e-05	0.0229	CrCbGaD
Propranolol—Esmolol—ADRB1—coronary artery disease	4.68e-05	0.0216	CrCbGaD
Propranolol—Bevantolol—ADRB1—coronary artery disease	4.62e-05	0.0213	CrCbGaD
Propranolol—Carteolol—ADRB2—coronary artery disease	4.42e-05	0.0204	CrCbGaD
Propranolol—Bopindolol—ADRB1—coronary artery disease	4.28e-05	0.0198	CrCbGaD
Propranolol—Betaxolol—ADRB1—coronary artery disease	4.12e-05	0.019	CrCbGaD
Propranolol—Atenolol—ADRB1—coronary artery disease	4.09e-05	0.0189	CrCbGaD
Propranolol—Penbutolol—ADRB1—coronary artery disease	4.09e-05	0.0189	CrCbGaD
Propranolol—Bisoprolol—ADRB1—coronary artery disease	3.98e-05	0.0184	CrCbGaD
Propranolol—Esmolol—ADRB2—coronary artery disease	3.94e-05	0.0182	CrCbGaD
Propranolol—Bevantolol—ADRB2—coronary artery disease	3.89e-05	0.018	CrCbGaD
Propranolol—Acebutolol—ADRB1—coronary artery disease	3.77e-05	0.0174	CrCbGaD
Propranolol—Oxprenolol—ADRB1—coronary artery disease	3.74e-05	0.0173	CrCbGaD
Propranolol—Bopindolol—ADRB2—coronary artery disease	3.6e-05	0.0166	CrCbGaD
Propranolol—Betaxolol—ADRB2—coronary artery disease	3.47e-05	0.016	CrCbGaD
Propranolol—Atenolol—ADRB2—coronary artery disease	3.44e-05	0.0159	CrCbGaD
Propranolol—Penbutolol—ADRB2—coronary artery disease	3.44e-05	0.0159	CrCbGaD
Propranolol—Alprenolol—ADRB1—coronary artery disease	3.42e-05	0.0158	CrCbGaD
Propranolol—Bisoprolol—ADRB2—coronary artery disease	3.35e-05	0.0155	CrCbGaD
Propranolol—Metoprolol—ADRB1—coronary artery disease	3.18e-05	0.0147	CrCbGaD
Propranolol—Acebutolol—ADRB2—coronary artery disease	3.17e-05	0.0146	CrCbGaD
Propranolol—Carvedilol—VEGFA—coronary artery disease	3.16e-05	0.0146	CrCbGaD
Propranolol—Oxprenolol—ADRB2—coronary artery disease	3.15e-05	0.0145	CrCbGaD
Propranolol—Terbinafine—CYP2C19—coronary artery disease	3.1e-05	0.0143	CrCbGaD
Propranolol—Constipation—Captopril—coronary artery disease	3.1e-05	0.000466	CcSEcCtD
Propranolol—Dyspepsia—Perindopril—coronary artery disease	3.1e-05	0.000466	CcSEcCtD
Propranolol—Gastrointestinal pain—Enalapril—coronary artery disease	3.09e-05	0.000464	CcSEcCtD
Propranolol—Body temperature increased—Pravastatin—coronary artery disease	3.09e-05	0.000464	CcSEcCtD
Propranolol—Abdominal pain—Pravastatin—coronary artery disease	3.09e-05	0.000464	CcSEcCtD
Propranolol—Dizziness—Clopidogrel—coronary artery disease	3.07e-05	0.000462	CcSEcCtD
Propranolol—Paraesthesia—Furosemide—coronary artery disease	3.07e-05	0.000462	CcSEcCtD
Propranolol—Decreased appetite—Perindopril—coronary artery disease	3.06e-05	0.00046	CcSEcCtD
Propranolol—Dizziness—Lovastatin—coronary artery disease	3.05e-05	0.000459	CcSEcCtD
Propranolol—Gastrointestinal pain—Telmisartan—coronary artery disease	3.05e-05	0.000458	CcSEcCtD
Propranolol—Vertigo—Timolol—coronary artery disease	3.04e-05	0.000458	CcSEcCtD
Propranolol—Somnolence—Furosemide—coronary artery disease	3.04e-05	0.000457	CcSEcCtD
Propranolol—Gastrointestinal disorder—Perindopril—coronary artery disease	3.04e-05	0.000457	CcSEcCtD
Propranolol—Diarrhoea—Eplerenone—coronary artery disease	3.03e-05	0.000456	CcSEcCtD
Propranolol—Fatigue—Perindopril—coronary artery disease	3.03e-05	0.000456	CcSEcCtD
Propranolol—Cough—Ramipril—coronary artery disease	3.02e-05	0.000455	CcSEcCtD
Propranolol—Urticaria—Trandolapril—coronary artery disease	3.01e-05	0.000453	CcSEcCtD
Propranolol—Constipation—Perindopril—coronary artery disease	3.01e-05	0.000452	CcSEcCtD
Propranolol—Pain—Perindopril—coronary artery disease	3.01e-05	0.000452	CcSEcCtD
Propranolol—Vomiting—Fenofibrate—coronary artery disease	3.01e-05	0.000452	CcSEcCtD
Propranolol—Hypersensitivity—Valsartan—coronary artery disease	3e-05	0.000452	CcSEcCtD
Propranolol—Convulsion—Ramipril—coronary artery disease	3e-05	0.000452	CcSEcCtD
Propranolol—Urticaria—Enalapril—coronary artery disease	3e-05	0.000451	CcSEcCtD
Propranolol—Body temperature increased—Trandolapril—coronary artery disease	3e-05	0.000451	CcSEcCtD
Propranolol—Abdominal pain—Trandolapril—coronary artery disease	3e-05	0.000451	CcSEcCtD
Propranolol—Dizziness—Ezetimibe—coronary artery disease	2.99e-05	0.00045	CcSEcCtD
Propranolol—Abdominal pain—Enalapril—coronary artery disease	2.98e-05	0.000449	CcSEcCtD
Propranolol—Body temperature increased—Enalapril—coronary artery disease	2.98e-05	0.000449	CcSEcCtD
Propranolol—Insomnia—Losartan—coronary artery disease	2.98e-05	0.000449	CcSEcCtD
Propranolol—Rash—Fenofibrate—coronary artery disease	2.98e-05	0.000448	CcSEcCtD
Propranolol—Dermatitis—Fenofibrate—coronary artery disease	2.98e-05	0.000448	CcSEcCtD
Propranolol—Decreased appetite—Furosemide—coronary artery disease	2.97e-05	0.000447	CcSEcCtD
Propranolol—Paraesthesia—Losartan—coronary artery disease	2.96e-05	0.000445	CcSEcCtD
Propranolol—Gastrointestinal pain—Captopril—coronary artery disease	2.96e-05	0.000445	CcSEcCtD
Propranolol—Urticaria—Telmisartan—coronary artery disease	2.96e-05	0.000445	CcSEcCtD
Propranolol—Cough—Timolol—coronary artery disease	2.96e-05	0.000445	CcSEcCtD
Propranolol—Vomiting—Clopidogrel—coronary artery disease	2.95e-05	0.000445	CcSEcCtD
Propranolol—Diarrhoea—Simvastatin—coronary artery disease	2.95e-05	0.000444	CcSEcCtD
Propranolol—Gastrointestinal disorder—Furosemide—coronary artery disease	2.95e-05	0.000444	CcSEcCtD
Propranolol—Fatigue—Furosemide—coronary artery disease	2.95e-05	0.000443	CcSEcCtD
Propranolol—Pindolol—ADRB1—coronary artery disease	2.94e-05	0.0136	CrCbGaD
Propranolol—Abdominal pain—Telmisartan—coronary artery disease	2.94e-05	0.000443	CcSEcCtD
Propranolol—Body temperature increased—Telmisartan—coronary artery disease	2.94e-05	0.000443	CcSEcCtD
Propranolol—Dyspnoea—Losartan—coronary artery disease	2.94e-05	0.000442	CcSEcCtD
Propranolol—Vomiting—Lovastatin—coronary artery disease	2.94e-05	0.000442	CcSEcCtD
Propranolol—Somnolence—Losartan—coronary artery disease	2.93e-05	0.000441	CcSEcCtD
Propranolol—Dizziness—Eplerenone—coronary artery disease	2.93e-05	0.000441	CcSEcCtD
Propranolol—Rash—Clopidogrel—coronary artery disease	2.93e-05	0.000441	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	2.93e-05	0.000441	CcSEcCtD
Propranolol—Dermatitis—Clopidogrel—coronary artery disease	2.93e-05	0.00044	CcSEcCtD
Propranolol—Asthenia—Valsartan—coronary artery disease	2.93e-05	0.00044	CcSEcCtD
Propranolol—Constipation—Furosemide—coronary artery disease	2.92e-05	0.00044	CcSEcCtD
Propranolol—Pain—Furosemide—coronary artery disease	2.92e-05	0.00044	CcSEcCtD
Propranolol—Hypersensitivity—Niacin—coronary artery disease	2.92e-05	0.000439	CcSEcCtD
Propranolol—Asthenia—Olmesartan—coronary artery disease	2.91e-05	0.000438	CcSEcCtD
Propranolol—Rash—Lovastatin—coronary artery disease	2.91e-05	0.000438	CcSEcCtD
Propranolol—Dermatitis—Lovastatin—coronary artery disease	2.91e-05	0.000437	CcSEcCtD
Propranolol—Dyspepsia—Losartan—coronary artery disease	2.9e-05	0.000437	CcSEcCtD
Propranolol—Alprenolol—ADRB2—coronary artery disease	2.88e-05	0.0133	CrCbGaD
Propranolol—Vomiting—Ezetimibe—coronary artery disease	2.88e-05	0.000433	CcSEcCtD
Propranolol—Hypersensitivity—Pravastatin—coronary artery disease	2.88e-05	0.000433	CcSEcCtD
Propranolol—Gastrointestinal pain—Perindopril—coronary artery disease	2.88e-05	0.000433	CcSEcCtD
Propranolol—Decreased appetite—Losartan—coronary artery disease	2.87e-05	0.000431	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	2.86e-05	0.000431	CcSEcCtD
Propranolol—Abdominal pain—Captopril—coronary artery disease	2.86e-05	0.000431	CcSEcCtD
Propranolol—Body temperature increased—Captopril—coronary artery disease	2.86e-05	0.000431	CcSEcCtD
Propranolol—Dizziness—Simvastatin—coronary artery disease	2.86e-05	0.00043	CcSEcCtD
Propranolol—Rash—Ezetimibe—coronary artery disease	2.85e-05	0.000429	CcSEcCtD
Propranolol—Dermatitis—Ezetimibe—coronary artery disease	2.85e-05	0.000429	CcSEcCtD
Propranolol—Asthenia—Niacin—coronary artery disease	2.84e-05	0.000428	CcSEcCtD
Propranolol—Fatigue—Losartan—coronary artery disease	2.84e-05	0.000428	CcSEcCtD
Propranolol—Anaphylactic shock—Ramipril—coronary artery disease	2.83e-05	0.000425	CcSEcCtD
Propranolol—Vertigo—Lisinopril—coronary artery disease	2.82e-05	0.000425	CcSEcCtD
Propranolol—Pain—Losartan—coronary artery disease	2.82e-05	0.000424	CcSEcCtD
Propranolol—Constipation—Losartan—coronary artery disease	2.82e-05	0.000424	CcSEcCtD
Propranolol—Vomiting—Eplerenone—coronary artery disease	2.82e-05	0.000424	CcSEcCtD
Propranolol—Nausea—Fenofibrate—coronary artery disease	2.81e-05	0.000422	CcSEcCtD
Propranolol—Asthenia—Pravastatin—coronary artery disease	2.8e-05	0.000421	CcSEcCtD
Propranolol—Gastrointestinal pain—Furosemide—coronary artery disease	2.8e-05	0.00042	CcSEcCtD
Propranolol—Rash—Eplerenone—coronary artery disease	2.79e-05	0.00042	CcSEcCtD
Propranolol—Urticaria—Perindopril—coronary artery disease	2.79e-05	0.00042	CcSEcCtD
Propranolol—Hypersensitivity—Trandolapril—coronary artery disease	2.79e-05	0.00042	CcSEcCtD
Propranolol—Dermatitis—Eplerenone—coronary artery disease	2.79e-05	0.00042	CcSEcCtD
Propranolol—Diarrhoea—Valsartan—coronary artery disease	2.79e-05	0.00042	CcSEcCtD
Propranolol—Hypersensitivity—Enalapril—coronary artery disease	2.78e-05	0.000418	CcSEcCtD
Propranolol—Body temperature increased—Perindopril—coronary artery disease	2.78e-05	0.000418	CcSEcCtD
Propranolol—Abdominal pain—Perindopril—coronary artery disease	2.78e-05	0.000418	CcSEcCtD
Propranolol—Diarrhoea—Olmesartan—coronary artery disease	2.78e-05	0.000418	CcSEcCtD
Propranolol—Nervous system disorder—Ramipril—coronary artery disease	2.77e-05	0.000417	CcSEcCtD
Propranolol—Anaphylactic shock—Timolol—coronary artery disease	2.76e-05	0.000416	CcSEcCtD
Propranolol—Nausea—Clopidogrel—coronary artery disease	2.76e-05	0.000415	CcSEcCtD
Propranolol—Skin disorder—Ramipril—coronary artery disease	2.75e-05	0.000413	CcSEcCtD
Propranolol—Infection—Timolol—coronary artery disease	2.75e-05	0.000413	CcSEcCtD
Propranolol—Vomiting—Simvastatin—coronary artery disease	2.75e-05	0.000413	CcSEcCtD
Propranolol—Hypersensitivity—Telmisartan—coronary artery disease	2.74e-05	0.000413	CcSEcCtD
Propranolol—Cough—Lisinopril—coronary artery disease	2.74e-05	0.000413	CcSEcCtD
Propranolol—Nausea—Lovastatin—coronary artery disease	2.74e-05	0.000413	CcSEcCtD
Propranolol—Rash—Simvastatin—coronary artery disease	2.72e-05	0.00041	CcSEcCtD
Propranolol—Dermatitis—Simvastatin—coronary artery disease	2.72e-05	0.000409	CcSEcCtD
Propranolol—Asthenia—Trandolapril—coronary artery disease	2.72e-05	0.000409	CcSEcCtD
Propranolol—Urticaria—Furosemide—coronary artery disease	2.72e-05	0.000408	CcSEcCtD
Propranolol—Diarrhoea—Niacin—coronary artery disease	2.71e-05	0.000408	CcSEcCtD
Propranolol—Nervous system disorder—Timolol—coronary artery disease	2.71e-05	0.000408	CcSEcCtD
Propranolol—Asthenia—Enalapril—coronary artery disease	2.71e-05	0.000408	CcSEcCtD
Propranolol—Abdominal pain—Furosemide—coronary artery disease	2.7e-05	0.000406	CcSEcCtD
Propranolol—Body temperature increased—Furosemide—coronary artery disease	2.7e-05	0.000406	CcSEcCtD
Propranolol—Gastrointestinal pain—Losartan—coronary artery disease	2.7e-05	0.000406	CcSEcCtD
Propranolol—Dizziness—Valsartan—coronary artery disease	2.7e-05	0.000406	CcSEcCtD
Propranolol—Nausea—Ezetimibe—coronary artery disease	2.69e-05	0.000405	CcSEcCtD
Propranolol—Skin disorder—Timolol—coronary artery disease	2.69e-05	0.000404	CcSEcCtD
Propranolol—Dizziness—Olmesartan—coronary artery disease	2.68e-05	0.000404	CcSEcCtD
Propranolol—Metoprolol—ADRB2—coronary artery disease	2.68e-05	0.0124	CrCbGaD
Propranolol—Asthenia—Telmisartan—coronary artery disease	2.67e-05	0.000402	CcSEcCtD
Propranolol—Diarrhoea—Pravastatin—coronary artery disease	2.67e-05	0.000402	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.66e-05	0.0004	CcSEcCtD
Propranolol—Nausea—Eplerenone—coronary artery disease	2.63e-05	0.000396	CcSEcCtD
Propranolol—Dizziness—Niacin—coronary artery disease	2.62e-05	0.000394	CcSEcCtD
Propranolol—Urticaria—Losartan—coronary artery disease	2.62e-05	0.000394	CcSEcCtD
Propranolol—Abdominal pain—Losartan—coronary artery disease	2.61e-05	0.000392	CcSEcCtD
Propranolol—Body temperature increased—Losartan—coronary artery disease	2.61e-05	0.000392	CcSEcCtD
Propranolol—Asthenia—Captopril—coronary artery disease	2.6e-05	0.000391	CcSEcCtD
Propranolol—Diarrhoea—Trandolapril—coronary artery disease	2.59e-05	0.00039	CcSEcCtD
Propranolol—Vomiting—Valsartan—coronary artery disease	2.59e-05	0.00039	CcSEcCtD
Propranolol—Diarrhoea—Enalapril—coronary artery disease	2.58e-05	0.000389	CcSEcCtD
Propranolol—Dizziness—Pravastatin—coronary artery disease	2.58e-05	0.000388	CcSEcCtD
Propranolol—Vomiting—Olmesartan—coronary artery disease	2.58e-05	0.000388	CcSEcCtD
Propranolol—Rash—Valsartan—coronary artery disease	2.57e-05	0.000387	CcSEcCtD
Propranolol—Dermatitis—Valsartan—coronary artery disease	2.57e-05	0.000386	CcSEcCtD
Propranolol—Nausea—Simvastatin—coronary artery disease	2.56e-05	0.000386	CcSEcCtD
Propranolol—Anaphylactic shock—Lisinopril—coronary artery disease	2.56e-05	0.000386	CcSEcCtD
Propranolol—Rash—Olmesartan—coronary artery disease	2.56e-05	0.000385	CcSEcCtD
Propranolol—Insomnia—Ramipril—coronary artery disease	2.56e-05	0.000385	CcSEcCtD
Propranolol—Dermatitis—Olmesartan—coronary artery disease	2.56e-05	0.000385	CcSEcCtD
Propranolol—Diarrhoea—Telmisartan—coronary artery disease	2.55e-05	0.000383	CcSEcCtD
Propranolol—Infection—Lisinopril—coronary artery disease	2.55e-05	0.000383	CcSEcCtD
Propranolol—Paraesthesia—Ramipril—coronary artery disease	2.54e-05	0.000382	CcSEcCtD
Propranolol—Asthenia—Perindopril—coronary artery disease	2.52e-05	0.00038	CcSEcCtD
Propranolol—Dyspnoea—Ramipril—coronary artery disease	2.52e-05	0.000379	CcSEcCtD
Propranolol—Vomiting—Niacin—coronary artery disease	2.52e-05	0.000379	CcSEcCtD
Propranolol—Hypersensitivity—Furosemide—coronary artery disease	2.52e-05	0.000379	CcSEcCtD
Propranolol—Somnolence—Ramipril—coronary artery disease	2.51e-05	0.000378	CcSEcCtD
Propranolol—Dizziness—Trandolapril—coronary artery disease	2.51e-05	0.000377	CcSEcCtD
Propranolol—Insomnia—Timolol—coronary artery disease	2.5e-05	0.000376	CcSEcCtD
Propranolol—Rash—Niacin—coronary artery disease	2.5e-05	0.000376	CcSEcCtD
Propranolol—Dermatitis—Niacin—coronary artery disease	2.5e-05	0.000376	CcSEcCtD
Propranolol—Dizziness—Enalapril—coronary artery disease	2.5e-05	0.000376	CcSEcCtD
Propranolol—Skin disorder—Lisinopril—coronary artery disease	2.49e-05	0.000375	CcSEcCtD
Propranolol—Dyspepsia—Ramipril—coronary artery disease	2.49e-05	0.000374	CcSEcCtD
Propranolol—Paraesthesia—Timolol—coronary artery disease	2.48e-05	0.000373	CcSEcCtD
Propranolol—Vomiting—Pravastatin—coronary artery disease	2.48e-05	0.000373	CcSEcCtD
Propranolol—Diarrhoea—Captopril—coronary artery disease	2.48e-05	0.000373	CcSEcCtD
Propranolol—Pindolol—ADRB2—coronary artery disease	2.48e-05	0.0114	CrCbGaD
Propranolol—Dyspnoea—Timolol—coronary artery disease	2.46e-05	0.000371	CcSEcCtD
Propranolol—Dizziness—Telmisartan—coronary artery disease	2.46e-05	0.00037	CcSEcCtD
Propranolol—Rash—Pravastatin—coronary artery disease	2.46e-05	0.00037	CcSEcCtD
Propranolol—Dermatitis—Pravastatin—coronary artery disease	2.46e-05	0.00037	CcSEcCtD
Propranolol—Decreased appetite—Ramipril—coronary artery disease	2.46e-05	0.00037	CcSEcCtD
Propranolol—Somnolence—Timolol—coronary artery disease	2.46e-05	0.00037	CcSEcCtD
Propranolol—Asthenia—Furosemide—coronary artery disease	2.45e-05	0.000369	CcSEcCtD
Propranolol—Gastrointestinal disorder—Ramipril—coronary artery disease	2.44e-05	0.000367	CcSEcCtD
Propranolol—Fatigue—Ramipril—coronary artery disease	2.44e-05	0.000367	CcSEcCtD
Propranolol—Dyspepsia—Timolol—coronary artery disease	2.43e-05	0.000366	CcSEcCtD
Propranolol—Hypersensitivity—Losartan—coronary artery disease	2.43e-05	0.000366	CcSEcCtD
Propranolol—Nausea—Valsartan—coronary artery disease	2.42e-05	0.000364	CcSEcCtD
Propranolol—Constipation—Ramipril—coronary artery disease	2.42e-05	0.000364	CcSEcCtD
Propranolol—Nausea—Olmesartan—coronary artery disease	2.41e-05	0.000363	CcSEcCtD
Propranolol—Vomiting—Trandolapril—coronary artery disease	2.41e-05	0.000363	CcSEcCtD
Propranolol—Diarrhoea—Perindopril—coronary artery disease	2.41e-05	0.000362	CcSEcCtD
Propranolol—Decreased appetite—Timolol—coronary artery disease	2.4e-05	0.000362	CcSEcCtD
Propranolol—Vomiting—Enalapril—coronary artery disease	2.4e-05	0.000361	CcSEcCtD
Propranolol—Dizziness—Captopril—coronary artery disease	2.39e-05	0.00036	CcSEcCtD
Propranolol—Rash—Trandolapril—coronary artery disease	2.39e-05	0.00036	CcSEcCtD
Propranolol—Dermatitis—Trandolapril—coronary artery disease	2.39e-05	0.000359	CcSEcCtD
Propranolol—Gastrointestinal disorder—Timolol—coronary artery disease	2.39e-05	0.000359	CcSEcCtD
Propranolol—Fatigue—Timolol—coronary artery disease	2.38e-05	0.000359	CcSEcCtD
Propranolol—Rash—Enalapril—coronary artery disease	2.38e-05	0.000358	CcSEcCtD
Propranolol—Dermatitis—Enalapril—coronary artery disease	2.38e-05	0.000358	CcSEcCtD
Propranolol—Vomiting—Telmisartan—coronary artery disease	2.37e-05	0.000356	CcSEcCtD
Propranolol—Asthenia—Losartan—coronary artery disease	2.37e-05	0.000356	CcSEcCtD
Propranolol—Pain—Timolol—coronary artery disease	2.36e-05	0.000356	CcSEcCtD
Propranolol—Nausea—Niacin—coronary artery disease	2.36e-05	0.000354	CcSEcCtD
Propranolol—Rash—Telmisartan—coronary artery disease	2.35e-05	0.000353	CcSEcCtD
Propranolol—Propafenone—ADRB1—coronary artery disease	2.35e-05	0.0108	CrCbGaD
Propranolol—Dermatitis—Telmisartan—coronary artery disease	2.35e-05	0.000353	CcSEcCtD
Propranolol—Diarrhoea—Furosemide—coronary artery disease	2.34e-05	0.000352	CcSEcCtD
Propranolol—Dizziness—Perindopril—coronary artery disease	2.33e-05	0.00035	CcSEcCtD
Propranolol—Insomnia—Lisinopril—coronary artery disease	2.32e-05	0.000349	CcSEcCtD
Propranolol—Nausea—Pravastatin—coronary artery disease	2.32e-05	0.000349	CcSEcCtD
Propranolol—Gastrointestinal pain—Ramipril—coronary artery disease	2.31e-05	0.000348	CcSEcCtD
Propranolol—Metoprolol—CYP2C19—coronary artery disease	2.3e-05	0.0106	CrCbGaD
Propranolol—Paraesthesia—Lisinopril—coronary artery disease	2.3e-05	0.000346	CcSEcCtD
Propranolol—Vomiting—Captopril—coronary artery disease	2.3e-05	0.000346	CcSEcCtD
Propranolol—Dyspnoea—Lisinopril—coronary artery disease	2.29e-05	0.000344	CcSEcCtD
Propranolol—Rash—Captopril—coronary artery disease	2.28e-05	0.000343	CcSEcCtD
Propranolol—Dermatitis—Captopril—coronary artery disease	2.28e-05	0.000343	CcSEcCtD
Propranolol—Somnolence—Lisinopril—coronary artery disease	2.28e-05	0.000343	CcSEcCtD
Propranolol—Gastrointestinal pain—Timolol—coronary artery disease	2.26e-05	0.00034	CcSEcCtD
Propranolol—Dizziness—Furosemide—coronary artery disease	2.26e-05	0.00034	CcSEcCtD
Propranolol—Dyspepsia—Lisinopril—coronary artery disease	2.26e-05	0.00034	CcSEcCtD
Propranolol—Diarrhoea—Losartan—coronary artery disease	2.26e-05	0.000339	CcSEcCtD
Propranolol—Nausea—Trandolapril—coronary artery disease	2.25e-05	0.000339	CcSEcCtD
Propranolol—Urticaria—Ramipril—coronary artery disease	2.25e-05	0.000338	CcSEcCtD
Propranolol—Nausea—Enalapril—coronary artery disease	2.24e-05	0.000337	CcSEcCtD
Propranolol—Vomiting—Perindopril—coronary artery disease	2.24e-05	0.000336	CcSEcCtD
Propranolol—Abdominal pain—Ramipril—coronary artery disease	2.24e-05	0.000336	CcSEcCtD
Propranolol—Body temperature increased—Ramipril—coronary artery disease	2.24e-05	0.000336	CcSEcCtD
Propranolol—Decreased appetite—Lisinopril—coronary artery disease	2.23e-05	0.000335	CcSEcCtD
Propranolol—Rash—Perindopril—coronary artery disease	2.22e-05	0.000334	CcSEcCtD
Propranolol—Dermatitis—Perindopril—coronary artery disease	2.21e-05	0.000333	CcSEcCtD
Propranolol—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.21e-05	0.000333	CcSEcCtD
Propranolol—Nausea—Telmisartan—coronary artery disease	2.21e-05	0.000333	CcSEcCtD
Propranolol—Fatigue—Lisinopril—coronary artery disease	2.21e-05	0.000333	CcSEcCtD
Propranolol—Urticaria—Timolol—coronary artery disease	2.2e-05	0.00033	CcSEcCtD
Propranolol—Pain—Lisinopril—coronary artery disease	2.19e-05	0.00033	CcSEcCtD
Propranolol—Constipation—Lisinopril—coronary artery disease	2.19e-05	0.00033	CcSEcCtD
Propranolol—Body temperature increased—Timolol—coronary artery disease	2.19e-05	0.000329	CcSEcCtD
Propranolol—Abdominal pain—Timolol—coronary artery disease	2.19e-05	0.000329	CcSEcCtD
Propranolol—Dizziness—Losartan—coronary artery disease	2.18e-05	0.000328	CcSEcCtD
Propranolol—Vomiting—Furosemide—coronary artery disease	2.17e-05	0.000327	CcSEcCtD
Propranolol—Rash—Furosemide—coronary artery disease	2.16e-05	0.000324	CcSEcCtD
Propranolol—Dermatitis—Furosemide—coronary artery disease	2.15e-05	0.000324	CcSEcCtD
Propranolol—Nausea—Captopril—coronary artery disease	2.15e-05	0.000324	CcSEcCtD
Propranolol—Carvedilol—ADRB1—coronary artery disease	2.11e-05	0.00975	CrCbGaD
Propranolol—Gastrointestinal pain—Lisinopril—coronary artery disease	2.1e-05	0.000315	CcSEcCtD
Propranolol—Vomiting—Losartan—coronary artery disease	2.1e-05	0.000315	CcSEcCtD
Propranolol—Nausea—Perindopril—coronary artery disease	2.09e-05	0.000314	CcSEcCtD
Propranolol—Hypersensitivity—Ramipril—coronary artery disease	2.08e-05	0.000313	CcSEcCtD
Propranolol—Rash—Losartan—coronary artery disease	2.08e-05	0.000313	CcSEcCtD
Propranolol—Dermatitis—Losartan—coronary artery disease	2.08e-05	0.000313	CcSEcCtD
Propranolol—Urticaria—Lisinopril—coronary artery disease	2.04e-05	0.000306	CcSEcCtD
Propranolol—Hypersensitivity—Timolol—coronary artery disease	2.04e-05	0.000306	CcSEcCtD
Propranolol—Nausea—Furosemide—coronary artery disease	2.03e-05	0.000305	CcSEcCtD
Propranolol—Asthenia—Ramipril—coronary artery disease	2.03e-05	0.000305	CcSEcCtD
Propranolol—Abdominal pain—Lisinopril—coronary artery disease	2.03e-05	0.000305	CcSEcCtD
Propranolol—Body temperature increased—Lisinopril—coronary artery disease	2.03e-05	0.000305	CcSEcCtD
Propranolol—Asthenia—Timolol—coronary artery disease	1.98e-05	0.000298	CcSEcCtD
Propranolol—Nausea—Losartan—coronary artery disease	1.96e-05	0.000295	CcSEcCtD
Propranolol—Diarrhoea—Ramipril—coronary artery disease	1.93e-05	0.000291	CcSEcCtD
Propranolol—Duloxetine—HTR2A—coronary artery disease	1.9e-05	0.00875	CrCbGaD
Propranolol—Diarrhoea—Timolol—coronary artery disease	1.89e-05	0.000285	CcSEcCtD
Propranolol—Hypersensitivity—Lisinopril—coronary artery disease	1.89e-05	0.000284	CcSEcCtD
Propranolol—Dizziness—Ramipril—coronary artery disease	1.87e-05	0.000281	CcSEcCtD
Propranolol—Asthenia—Lisinopril—coronary artery disease	1.84e-05	0.000277	CcSEcCtD
Propranolol—Dizziness—Timolol—coronary artery disease	1.83e-05	0.000275	CcSEcCtD
Propranolol—Vomiting—Ramipril—coronary artery disease	1.8e-05	0.00027	CcSEcCtD
Propranolol—Rash—Ramipril—coronary artery disease	1.78e-05	0.000268	CcSEcCtD
Propranolol—Dermatitis—Ramipril—coronary artery disease	1.78e-05	0.000268	CcSEcCtD
Propranolol—Carvedilol—ADRB2—coronary artery disease	1.78e-05	0.0082	CrCbGaD
Propranolol—Vomiting—Timolol—coronary artery disease	1.76e-05	0.000264	CcSEcCtD
Propranolol—Diarrhoea—Lisinopril—coronary artery disease	1.75e-05	0.000264	CcSEcCtD
Propranolol—Rash—Timolol—coronary artery disease	1.74e-05	0.000262	CcSEcCtD
Propranolol—Dermatitis—Timolol—coronary artery disease	1.74e-05	0.000262	CcSEcCtD
Propranolol—Dizziness—Lisinopril—coronary artery disease	1.7e-05	0.000255	CcSEcCtD
Propranolol—Nausea—Ramipril—coronary artery disease	1.68e-05	0.000253	CcSEcCtD
Propranolol—Nausea—Timolol—coronary artery disease	1.64e-05	0.000247	CcSEcCtD
Propranolol—Vomiting—Lisinopril—coronary artery disease	1.63e-05	0.000245	CcSEcCtD
Propranolol—Rash—Lisinopril—coronary artery disease	1.62e-05	0.000243	CcSEcCtD
Propranolol—Dermatitis—Lisinopril—coronary artery disease	1.62e-05	0.000243	CcSEcCtD
Propranolol—Nausea—Lisinopril—coronary artery disease	1.52e-05	0.000229	CcSEcCtD
Propranolol—Atomoxetine—CYP2C19—coronary artery disease	1.22e-05	0.00565	CrCbGaD
Propranolol—Atomoxetine—HTR2A—coronary artery disease	9.93e-06	0.00458	CrCbGaD
Propranolol—CYP1A1—Metabolism—MTHFR—coronary artery disease	9.62e-07	2.72e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	9.61e-07	2.72e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—TGFB1—coronary artery disease	9.61e-07	2.72e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CXCL8—coronary artery disease	9.6e-07	2.72e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—HMOX1—coronary artery disease	9.56e-07	2.7e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—GSK3B—coronary artery disease	9.53e-07	2.7e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IGF1—coronary artery disease	9.51e-07	2.69e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—APOE—coronary artery disease	9.48e-07	2.68e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—MAPK1—coronary artery disease	9.47e-07	2.68e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GSTP1—coronary artery disease	9.46e-07	2.68e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CCL2—coronary artery disease	9.46e-07	2.68e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—POMC—coronary artery disease	9.46e-07	2.67e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CREB1—coronary artery disease	9.46e-07	2.67e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—VCAN—coronary artery disease	9.44e-07	2.67e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CAT—coronary artery disease	9.44e-07	2.67e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL6R—coronary artery disease	9.44e-07	2.67e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—MAPK1—coronary artery disease	9.42e-07	2.66e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PPARGC1A—coronary artery disease	9.38e-07	2.65e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—APOA1—coronary artery disease	9.37e-07	2.65e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ALDOA—coronary artery disease	9.37e-07	2.65e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—HMOX1—coronary artery disease	9.33e-07	2.64e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IGF1—coronary artery disease	9.3e-07	2.63e-05	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—AKT1—coronary artery disease	9.28e-07	2.62e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—MAPK1—coronary artery disease	9.26e-07	2.62e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CCL2—coronary artery disease	9.25e-07	2.62e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL6R—coronary artery disease	9.23e-07	2.61e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CAT—coronary artery disease	9.21e-07	2.6e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CASP3—coronary artery disease	9.19e-07	2.6e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—APOB—coronary artery disease	9.16e-07	2.59e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—AGT—coronary artery disease	9.14e-07	2.59e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—IL6—coronary artery disease	9.13e-07	2.58e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IGF1—coronary artery disease	9.1e-07	2.57e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—DCN—coronary artery disease	9.09e-07	2.57e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—MAPK1—coronary artery disease	9.05e-07	2.56e-05	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—PIK3CA—coronary artery disease	9.05e-07	2.56e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—SERPINE1—coronary artery disease	9.03e-07	2.55e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PTGS2—coronary artery disease	8.99e-07	2.54e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PTGS2—coronary artery disease	8.98e-07	2.54e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PLCB1—coronary artery disease	8.96e-07	2.53e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—APOE—coronary artery disease	8.96e-07	2.53e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CCND1—coronary artery disease	8.95e-07	2.53e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—APOB—coronary artery disease	8.94e-07	2.53e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GSTP1—coronary artery disease	8.92e-07	2.52e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GSTM1—coronary artery disease	8.91e-07	2.52e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—APOA1—coronary artery disease	8.86e-07	2.5e-05	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—PIK3CA—coronary artery disease	8.85e-07	2.5e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ALDH2—coronary artery disease	8.84e-07	2.5e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	8.84e-07	2.5e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—SERPINE1—coronary artery disease	8.84e-07	2.5e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—HMOX1—coronary artery disease	8.8e-07	2.49e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	8.79e-07	2.49e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—LPL—coronary artery disease	8.75e-07	2.47e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—FGF2—coronary artery disease	8.74e-07	2.47e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GSTM1—coronary artery disease	8.7e-07	2.46e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MMP9—coronary artery disease	8.69e-07	2.46e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ABCA1—coronary artery disease	8.69e-07	2.46e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CAT—coronary artery disease	8.68e-07	2.45e-05	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—PIK3CA—coronary artery disease	8.65e-07	2.45e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—SERPINE1—coronary artery disease	8.64e-07	2.44e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—NOS3—coronary artery disease	8.62e-07	2.44e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—HBA1—coronary artery disease	8.62e-07	2.44e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—LIPC—coronary artery disease	8.62e-07	2.44e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	8.62e-07	2.44e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP2C19—coronary artery disease	8.62e-07	2.44e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—APOC3—coronary artery disease	8.57e-07	2.42e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—FGF2—coronary artery disease	8.55e-07	2.42e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—LPL—coronary artery disease	8.54e-07	2.41e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GPX1—coronary artery disease	8.53e-07	2.41e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—LDLR—coronary artery disease	8.51e-07	2.41e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	8.48e-07	2.4e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—NOS3—coronary artery disease	8.44e-07	2.39e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—AKT1—coronary artery disease	8.43e-07	2.38e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—APOB—coronary artery disease	8.43e-07	2.38e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SLC9A1—coronary artery disease	8.41e-07	2.38e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GSTT1—coronary artery disease	8.41e-07	2.38e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GGT1—coronary artery disease	8.41e-07	2.38e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GOT1—coronary artery disease	8.41e-07	2.38e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—JAK2—coronary artery disease	8.38e-07	2.37e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—FGF2—coronary artery disease	8.36e-07	2.37e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GPX1—coronary artery disease	8.33e-07	2.36e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CETP—coronary artery disease	8.32e-07	2.35e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GCLC—coronary artery disease	8.32e-07	2.35e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CD36—coronary artery disease	8.31e-07	2.35e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PPARG—coronary artery disease	8.26e-07	2.34e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—NOS3—coronary artery disease	8.25e-07	2.33e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SDC1—coronary artery disease	8.22e-07	2.33e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—PIK3CA—coronary artery disease	8.21e-07	2.32e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PPP2CA—coronary artery disease	8.21e-07	2.32e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—JAK2—coronary artery disease	8.2e-07	2.32e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GSTM1—coronary artery disease	8.2e-07	2.32e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—PIK3CA—coronary artery disease	8.18e-07	2.31e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—POMC—coronary artery disease	8.15e-07	2.3e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CD36—coronary artery disease	8.11e-07	2.29e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—LPL—coronary artery disease	8.04e-07	2.28e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—PIK3CA—coronary artery disease	8.04e-07	2.27e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—JAK2—coronary artery disease	8.02e-07	2.27e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PPP2CA—coronary artery disease	8.01e-07	2.27e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—MTHFR—coronary artery disease	7.88e-07	2.23e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—PIK3CA—coronary artery disease	7.86e-07	2.22e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GPX1—coronary artery disease	7.85e-07	2.22e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PPARG—coronary artery disease	7.8e-07	2.21e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—VEGFA—coronary artery disease	7.8e-07	2.21e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PSMA6—coronary artery disease	7.77e-07	2.2e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PSMB5—coronary artery disease	7.77e-07	2.2e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—POMC—coronary artery disease	7.7e-07	2.18e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—MTHFR—coronary artery disease	7.69e-07	2.17e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CXCL8—coronary artery disease	7.65e-07	2.16e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CD36—coronary artery disease	7.64e-07	2.16e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CTGF—coronary artery disease	7.59e-07	2.15e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GSTP1—coronary artery disease	7.56e-07	2.14e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PPP2CA—coronary artery disease	7.55e-07	2.13e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—HMGCR—coronary artery disease	7.52e-07	2.13e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GOT2—coronary artery disease	7.52e-07	2.13e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	7.49e-07	2.12e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—AGT—coronary artery disease	7.48e-07	2.12e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CXCL8—coronary artery disease	7.48e-07	2.12e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—HMOX1—coronary artery disease	7.45e-07	2.11e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—ALB—coronary artery disease	7.43e-07	2.1e-05	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—AKT1—coronary artery disease	7.39e-07	2.09e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CAT—coronary artery disease	7.35e-07	2.08e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—APOE—coronary artery disease	7.33e-07	2.07e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CASP3—coronary artery disease	7.32e-07	2.07e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CXCL8—coronary artery disease	7.32e-07	2.07e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—AGT—coronary artery disease	7.3e-07	2.07e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—IL6—coronary artery disease	7.27e-07	2.06e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—APOA1—coronary artery disease	7.25e-07	2.05e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—MTHFR—coronary artery disease	7.24e-07	2.05e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—IL6—coronary artery disease	7.24e-07	2.05e-05	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—AKT1—coronary artery disease	7.23e-07	2.04e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CASP3—coronary artery disease	7.16e-07	2.03e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TGFB1—coronary artery disease	7.16e-07	2.02e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—APOE—coronary artery disease	7.16e-07	2.02e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—APOB—coronary artery disease	7.14e-07	2.02e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CCND1—coronary artery disease	7.13e-07	2.02e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—IL6—coronary artery disease	7.12e-07	2.01e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—NOS3—coronary artery disease	7.1e-07	2.01e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—APOA1—coronary artery disease	7.07e-07	2e-05	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	7.07e-07	2e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MAPK1—coronary artery disease	7.02e-07	1.99e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—ALB—coronary artery disease	7.02e-07	1.98e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CASP3—coronary artery disease	7e-07	1.98e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CCND1—coronary artery disease	6.97e-07	1.97e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—IL6—coronary artery disease	6.96e-07	1.97e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GSTM1—coronary artery disease	6.94e-07	1.96e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	6.94e-07	1.96e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MMP9—coronary artery disease	6.92e-07	1.96e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PLCB1—coronary artery disease	6.92e-07	1.96e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—AGT—coronary artery disease	6.88e-07	1.95e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CCND1—coronary artery disease	6.82e-07	1.93e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—LPL—coronary artery disease	6.82e-07	1.93e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MMP9—coronary artery disease	6.77e-07	1.91e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—APOE—coronary artery disease	6.74e-07	1.91e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—NOS3—coronary artery disease	6.71e-07	1.9e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	6.71e-07	1.9e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ABCA1—coronary artery disease	6.7e-07	1.9e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—AKT1—coronary artery disease	6.68e-07	1.89e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—APOA1—coronary artery disease	6.67e-07	1.89e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GPX1—coronary artery disease	6.65e-07	1.88e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MMP9—coronary artery disease	6.62e-07	1.87e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—AKT1—coronary artery disease	6.56e-07	1.86e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PTGS2—coronary artery disease	6.5e-07	1.84e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GOT1—coronary artery disease	6.49e-07	1.84e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GGT1—coronary artery disease	6.49e-07	1.84e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CD36—coronary artery disease	6.48e-07	1.83e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	6.42e-07	1.82e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PPP2CA—coronary artery disease	6.39e-07	1.81e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PPARG—coronary artery disease	6.39e-07	1.81e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—POMC—coronary artery disease	6.3e-07	1.78e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PPARG—coronary artery disease	6.23e-07	1.76e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	6.21e-07	1.76e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—POMC—coronary artery disease	6.15e-07	1.74e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PTGS2—coronary artery disease	6.14e-07	1.74e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—MTHFR—coronary artery disease	6.14e-07	1.74e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—PIK3CA—coronary artery disease	6.09e-07	1.72e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—VEGFA—coronary artery disease	6.08e-07	1.72e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	5.94e-07	1.68e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PPARG—coronary artery disease	5.87e-07	1.66e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GSTP1—coronary artery disease	5.83e-07	1.65e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—AGT—coronary artery disease	5.83e-07	1.65e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—POMC—coronary artery disease	5.79e-07	1.64e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	5.78e-07	1.63e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—HMOX1—coronary artery disease	5.75e-07	1.63e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ALB—coronary artery disease	5.74e-07	1.62e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—APOE—coronary artery disease	5.71e-07	1.62e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	5.7e-07	1.61e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CAT—coronary artery disease	5.67e-07	1.6e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—APOA1—coronary artery disease	5.65e-07	1.6e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ALB—coronary artery disease	5.6e-07	1.59e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	5.59e-07	1.58e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TGFB1—coronary artery disease	5.58e-07	1.58e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PIK3CA—coronary artery disease	5.53e-07	1.56e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PIK3CA—coronary artery disease	5.52e-07	1.56e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—APOB—coronary artery disease	5.51e-07	1.56e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—NOS3—coronary artery disease	5.49e-07	1.55e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MAPK1—coronary artery disease	5.47e-07	1.55e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	5.45e-07	1.54e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	5.41e-07	1.53e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IL6—coronary artery disease	5.4e-07	1.53e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—NOS3—coronary artery disease	5.36e-07	1.52e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GSTM1—coronary artery disease	5.36e-07	1.52e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	5.35e-07	1.51e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ALB—coronary artery disease	5.28e-07	1.49e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—LPL—coronary artery disease	5.26e-07	1.49e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GPX1—coronary artery disease	5.13e-07	1.45e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—NOS3—coronary artery disease	5.05e-07	1.43e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PTGS2—coronary artery disease	5.02e-07	1.42e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CD36—coronary artery disease	5e-07	1.41e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—AKT1—coronary artery disease	4.98e-07	1.41e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PPARG—coronary artery disease	4.98e-07	1.41e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PPP2CA—coronary artery disease	4.94e-07	1.4e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—POMC—coronary artery disease	4.91e-07	1.39e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PTGS2—coronary artery disease	4.9e-07	1.39e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	4.85e-07	1.37e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PIK3CA—coronary artery disease	4.75e-07	1.34e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—MTHFR—coronary artery disease	4.74e-07	1.34e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	4.64e-07	1.31e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PTGS2—coronary artery disease	4.62e-07	1.31e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—AKT1—coronary artery disease	4.52e-07	1.28e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—AKT1—coronary artery disease	4.51e-07	1.28e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—AGT—coronary artery disease	4.5e-07	1.27e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ALB—coronary artery disease	4.47e-07	1.27e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—APOE—coronary artery disease	4.41e-07	1.25e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—APOA1—coronary artery disease	4.36e-07	1.23e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL6—coronary artery disease	4.3e-07	1.22e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—NOS3—coronary artery disease	4.28e-07	1.21e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL6—coronary artery disease	4.2e-07	1.19e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL6—coronary artery disease	4.11e-07	1.16e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3CA—coronary artery disease	4e-07	1.13e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—AKT1—coronary artery disease	3.96e-07	1.12e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PTGS2—coronary artery disease	3.91e-07	1.11e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—AKT1—coronary artery disease	3.88e-07	1.1e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PPARG—coronary artery disease	3.84e-07	1.09e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—AKT1—coronary artery disease	3.79e-07	1.07e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—POMC—coronary artery disease	3.79e-07	1.07e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CA—coronary artery disease	3.78e-07	1.07e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ALB—coronary artery disease	3.45e-07	9.77e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NOS3—coronary artery disease	3.3e-07	9.34e-06	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—AKT1—coronary artery disease	3.27e-07	9.24e-06	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CA—coronary artery disease	3.09e-07	8.74e-06	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—AKT1—coronary artery disease	3.09e-07	8.73e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PTGS2—coronary artery disease	3.02e-07	8.54e-06	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CA—coronary artery disease	3.02e-07	8.53e-06	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CA—coronary artery disease	2.84e-07	8.04e-06	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—AKT1—coronary artery disease	2.52e-07	7.14e-06	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—AKT1—coronary artery disease	2.46e-07	6.97e-06	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CA—coronary artery disease	2.41e-07	6.81e-06	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—AKT1—coronary artery disease	2.32e-07	6.57e-06	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—AKT1—coronary artery disease	1.97e-07	5.56e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.86e-07	5.26e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—AKT1—coronary artery disease	1.52e-07	4.29e-06	CbGpPWpGaD
